Erwin Irdam
7Patents
3h-index
17Co-inventors
50Inventor score
Filing activity: Dec 21, 2012 → Aug 19, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11453641B2 | Methods of treating neurofibromatosis with N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide | Chemistry; Metallurgy | 17 | Active |
| US11066358B1 | Compositions of essentially pure form IV of N-((R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and uses thereof | Chemistry; Metallurgy | 10 | Active |
| US10208003B2 | Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds | Chemistry; Metallurgy | 3 | Active |
| US9512096B2 | Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds | Chemistry; Metallurgy | 3 | Active |
| US11291642B2 | Dimethyl fumarate particles and pharmaceutical compositions thereof | Human Necessities | 1 | Active |
| US11192856B2 | Process for preparing alpha-carboxamide pyrrolidine derivatives | Emerging Cross-Sectional Technologies | 0 | Active |
| US12037306B2 | Methods of treating neurofibromatosis type 1 with N-((R))-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-benzamide | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.